These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3428347)

  • 21. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur.
    Takagi K; Hasegawa T; Ogura Y; Yamaki K; Suzuki R; Satake T; Imaeda N; Mizukami Y
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):530-5. PubMed ID: 3429057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of the bioavailability and pharmacokinetic profile of a theophylline pellet formulation designed for once-daily dosage with a pellet preparation designed for twice-daily dosage].
    Keinke O
    Arzneimittelforschung; 1989 Nov; 39(11):1460-4. PubMed ID: 2619780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absolute and relative bioavailability of a slow release theophylline preparation in asthmatic children.
    Boner AL; De Stefano G; Vallone G; Plebani M; Ventura P
    J Int Med Res; 1987; 15(5):282-92. PubMed ID: 3678595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
    Gupta S; Raina RK; Samotra K; Gupta KL
    Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bioavailability of a delayed-action aminophylline preparation].
    Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
    Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circadian rhythm in theophylline disposition during a constant-rate intravenous infusion of aminophylline in the dog.
    Rackley RJ; Meyer MC; Straughn AB
    J Pharm Sci; 1988 Aug; 77(8):658-61. PubMed ID: 3210152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of food on the bioavailability of theophylline from a sustained-released theophylline preparation.
    Lohmann A; Dingler E; Sommer W
    Arzneimittelforschung; 1991 Jul; 41(7):732-4. PubMed ID: 1772462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The beagle dog as an animal model for a bioavailability study of controlled-release theophylline under the influence of food.
    Shiu GK; LeMarchand A; Sager AO; Velagapudi RB; Skelly JP
    Pharm Res; 1989 Dec; 6(12):1039-42. PubMed ID: 2622858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetics of theophylline and aminophylline in man.
    Aslaksen A; Bakke OM; Vigander T
    Br J Clin Pharmacol; 1981 Mar; 11(3):269-73. PubMed ID: 7213528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Theophylline absorption from two sustained-release products. Implications for therapeutic drug monitoring.
    Rogers RJ; Wiener MB; Hill MR; Szefler SJ
    Am Rev Respir Dis; 1987 Nov; 136(5):1168-73. PubMed ID: 3674579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability of two Soviet sustained-release theophylline formulations in comparison with TheoDur.
    Kiivet RA; Teder P; Pruunsild T; Svensson JO
    Pharmacol Toxicol; 1992 Nov; 71(5):388-90. PubMed ID: 1448452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
    Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disposition and clinical pharmacokinetics of theophylline after administration of a new sustained release tablet.
    Jonkman JH; Berg WC; de Vries K; de Zeeuw RA; Schoenmaker R; Grimberg N
    Eur J Clin Pharmacol; 1981; 21(1):39-44. PubMed ID: 7333345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bioequivalence of theophylline retard capsules in children and relation of metabolism to administration route].
    Berdel D; Bonnacker I; Süverkrüp R; von Berg A; Buhr W
    Pneumologie; 1990 Feb; 44 Suppl 1():285-6. PubMed ID: 2367391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
    Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of two sustained-release theophylline preparations in adult patients with obstructive airways disease.
    Harkaway PS; Conlon PF; Hirsh JD; Allen WT
    J Clin Pharmacol; 1985 Sep; 25(6):444-7. PubMed ID: 4056079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose conversion from aminophylline to theophylline in preterm infants.
    Reese J; Prentice G; Yu VY
    Arch Dis Child Fetal Neonatal Ed; 1994 Jul; 71(1):F51-2. PubMed ID: 8092873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative bioavailability and bioequivalence study of theophylline sustained release formulations.
    Vergin H; Mahr G; Winterhalter B; Wigand R
    Arzneimittelforschung; 2003; 53(9):635-9. PubMed ID: 14558437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Theophylline pharmacokinetics following single and repeated administration of slow-release capsules.
    Torrent J; Izquierdo I; Barbanoj MJ; Obach R; Nomen M; Jane F
    Eur J Drug Metab Pharmacokinet; 1988; 13(4):225-30. PubMed ID: 3243316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simple conversion from intravenous aminophylline to twice daily oral theophylline.
    Pleasants RA; Williams DM
    Chest; 1989 Dec; 96(6):1440. PubMed ID: 2582862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.